Avvinity Therapeutics Overview
- Founded
- 2016
- Status
- Private
- Latest Deal Type
- Series 1
- Latest Deal Amount
- $4M
- Investors
- 5
Avvinity Therapeutics General Information
Description
Operator of an immunotherapy company intended to discover and develop multiple candidate molecules. The company's patent portfolio exemplifies the use of antibodies, antibody fragments, RNA/DNA, Aptamers and small molecules as targeting domains, enabling healhcare institutes to access the technology for the treatment of both solid tumours and leukemia.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- First Floor Thavies Inn House
- 3-4 Holborn Circus
- London EC1N 2HA
- England, United Kingdom
Avvinity Therapeutics Timeline
Avvinity Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Seed Round | 01-Aug-2020 | $4M | 00.000 | Completed | Generating Revenue | |
| 3. Corporate | 06-Aug-2019 | 00000 | 00.000 | 0000 | Completed | Generating Revenue |
| 2. Corporate | 03-Aug-2018 | $1.84M | $1.84M | 000.00 | Completed | Generating Revenue |
| 1. Joint Venture | 02-Mar-2016 | $110M | 00000 | Completed | Startup |
Avvinity Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 |
Avvinity Therapeutics Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Nick Staples Ph.D | Interim Chief Executive Officer |
Avvinity Therapeutics Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Jonathan Synett | Centauri Therapeutics | Board Member | 000 0000 |
| Michael Westby Ph.D | Centauri Therapeutics | Board Member | 000 0000 |
| Pauline Stasiak Ph.D | LifeArc | Board Member | 000 0000 |
Avvinity Therapeutics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Government of UK | Government | Minority | 000 0000 | 000000 0 | |
| LifeArc | Venture Capital | Minority | 000 0000 | 000000 0 | |
| NCL Technology Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Centauri Therapeutics | PE-Backed Company | Majority | 000 0000 | 000000 0 | |
| Horizon Discovery | Corporation | Minority | 000 0000 | 000000 0 |